China's major state-owned banks are set to reduce existing mortgage rates by 30 basis points below the Loan Prime Rate starting October 25, as part of efforts to stimulate the economy.
In a significant move to stimulate the economy, China's major state-owned banks have announced plans to cut existing mortgage rates by 30 basis points below the benchmark Loan Prime Rate (LPR) starting October 25. This decision comes as part of a broader strategy by Chinese authorities to boost the property market and address weak domestic demand.
The banks involved in this initiative include some of the largest financial institutions in China, such as the Industrial and Commercial Bank of China, Agricultural Bank of China, Bank of China, and China Construction Bank. These banks have stated that the rate adjustments will be implemented in batches, and customers will not need to apply for the changes.
The People's Bank of China had previously requested commercial banks to lower interest rates on existing mortgage loans by the end of October, as part of a series of stimulus measures aimed at reviving an economy that has been struggling with a prolonged property sector crisis and low consumption levels.
The rate cuts will apply to most existing mortgages, except for second homes in major cities like Beijing, Shanghai, and Shenzhen, where rates will be adjusted to the local lower limit. This move is expected to ease the financial burden on homeowners and potentially increase consumer spending, which is crucial for economic recovery.
Economists have noted that while these measures are a step in the right direction, further actions may be necessary to fully address the economic challenges facing China. The Finance Minister is expected to announce additional fiscal stimulus measures in the coming days, which could provide further support to the economy.
Party City, a leading retailer in the party supplies industry, has announced the closure of all its stores following financial struggles and a recent bankruptcy filing. The company, which has been in business for nearly 40 years, cited inflation and decreased consumer spending as key factors in its decision to wind down operations.
Honda and Nissan are reportedly in talks for a potential merger to address challenges in the automotive industry, including competition from electric vehicle manufacturers.
Google proposes to modify its search engine agreements to address US antitrust concerns, while planning to appeal the ruling.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.
United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.